In Support of Magnani and Taylor
Arch Pathol Lab Med
.
2024 Jan 1;148(1):11.
doi: 10.5858/arpa.2023-0446-LE.
Authors
David J Dabbs
1
2
,
Luis A Chiriboga
3
,
Bharat Jasani
4
,
Mary A Kinloch
5
,
Keith D Miller
6
,
Søren Nielsen
7
8
,
Matthias J Szabolcs
9
,
Emina Torlakovic
10
,
Steve Bogen
11
,
Suzanne Parry
12
,
Nils A 't Hart
13
Affiliations
1
Department of Pathology, PreludeDx, Laguna Hills, California.
2
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
3
Department of Pathology & Center for Biospecimen Research and Development, NYU Grossman School of Medicine, New York, New York.
4
Institute of Cancer & Genetics and Department of Cancer Pathology, Cardiff University, Cardiff, Wales, United Kingdom.
5
Department of Pathology and Laboratory Medicine, University of Saskatchewan & Saskatoon Health Authority, Saskatoon, Saskatchewan, Canada.
6
Department of Pathology, Institute of Biomedical Science, The Cancer Institute, University College, London Research, London, United Kingdom.
7
NordiQC, Aalborg, Denmark.
8
Department of Pathology, Aalborg University Hospital, Aalborg, Denmark.
9
Department of Pathology, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.
10
Department of Pathology, University of Saskatchewan & Saskatoon Health Authority, Royal University Hospital, Saskatoon, Saskatchewan, Canada.
11
Department of Pathology, Boston Cell Standards & Tufts Medical Center, Boston, Massachusetts.
12
Department of Immunocytochemistry and In-Situ Hybridisation, UK NEQAS-ICC/ISH, London, United Kingdom.
13
Department of Pathology, Isala, Zwolle, The Netherlands.
PMID:
38157868
DOI:
10.5858/arpa.2023-0446-LE
No abstract available